<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><description>领星是由中美生物医学数据科学家携手高年资肿瘤专家共同开创的临床科技和数据平台，提供肿瘤精准医疗和数据智能服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 08 May 2021 11:30:49 +0800</pubDate><image><url>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</url><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>AACR 2021丨结直肠癌患者临床病理与免疫疗效的相关性</title><link>https://mp.weixin.qq.com/s/ZukA3lcLaNtYFq0bC6m-1A</link><description></description><content:encoded><![CDATA[AACR 2021丨结直肠癌患者临床病理与免疫疗效的相关性]]></content:encoded><pubDate>Sat, 08 May 2021 09:48:43 +0800</pubDate></item><item><title>终于明白MSI-H/dMMR 肿瘤是什么了！</title><link>https://mp.weixin.qq.com/s/5yMaISPPzks0EPTDfeZZzA</link><description></description><content:encoded><![CDATA[终于明白MSI-H/dMMR 肿瘤是什么了！]]></content:encoded><pubDate>Thu, 06 May 2021 15:30:51 +0800</pubDate></item><item><title>速递丨全球首个CD38单抗新适应症在华获批！</title><link>https://mp.weixin.qq.com/s/X8YTkcWr_tQpADlQAeKqFg</link><description></description><content:encoded><![CDATA[速递丨全球首个CD38单抗新适应症在华获批！]]></content:encoded><pubDate>Thu, 06 May 2021 15:30:51 +0800</pubDate></item><item><title>精益求精，远超“指引”的8道质控，让领星更可靠！</title><link>https://mp.weixin.qq.com/s/7jkpIZYeopPpbG8LCpl3BQ</link><description></description><content:encoded><![CDATA[精益求精，远超“指引”的8道质控，让领星更可靠！]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:28:03 +0800</pubDate></item><item><title>一文盘点 PARP 抑制剂临床证据</title><link>https://mp.weixin.qq.com/s/cLhukZRmZWXOi1mrcs3PqQ</link><description></description><content:encoded><![CDATA[一文盘点 PARP 抑制剂临床证据]]></content:encoded><pubDate>Thu, 29 Apr 2021 11:52:43 +0800</pubDate></item><item><title>速递丨恒瑞医药CDK 4/6抑制剂上市申请获受理；Nature：科学家发现癌症代谢新机制</title><link>https://mp.weixin.qq.com/s/GN10s8N5Gt7oOpRsvAt0Ow</link><description></description><content:encoded><![CDATA[速递丨恒瑞医药CDK 4/6抑制剂上市申请获受理；Nature：科学家发现癌症代谢新机制]]></content:encoded><pubDate>Thu, 29 Apr 2021 11:52:43 +0800</pubDate></item><item><title>恭贺领星科学顾问委员会成员陈列平博士当选美国科学院院士</title><link>https://mp.weixin.qq.com/s/315fOy4wJP5YkVK2IszCdA</link><description></description><content:encoded><![CDATA[恭贺领星科学顾问委员会成员陈列平博士当选美国科学院院士]]></content:encoded><pubDate>Wed, 28 Apr 2021 16:16:21 +0800</pubDate></item><item><title>临床试验丨 结直肠癌（四）</title><link>https://mp.weixin.qq.com/s/pCJlKJS2MX0spKz2sGy3Tg</link><description></description><content:encoded><![CDATA[临床试验丨 结直肠癌（四）]]></content:encoded><pubDate>Wed, 28 Apr 2021 16:16:21 +0800</pubDate></item><item><title>血液ctDNA监测能否预测晚期黑色素瘤患者的靶向治疗预后？</title><link>https://mp.weixin.qq.com/s/ogQLY_uqT_Ok6pzgiZwlOg</link><description></description><content:encoded><![CDATA[血液ctDNA监测能否预测晚期黑色素瘤患者的靶向治疗预后？]]></content:encoded><pubDate>Mon, 26 Apr 2021 19:38:44 +0800</pubDate></item><item><title>速递丨奥拉帕尼单药疗法或有望治疗早期阶段的三阴性乳腺癌</title><link>https://mp.weixin.qq.com/s/C7BQAQdLRHoHgEkFcWnQQw</link><description></description><content:encoded><![CDATA[速递丨奥拉帕尼单药疗法或有望治疗早期阶段的三阴性乳腺癌]]></content:encoded><pubDate>Mon, 26 Apr 2021 19:38:44 +0800</pubDate></item><item><title>一文盘点侵袭性 B 细胞淋巴瘤免疫治疗药物</title><link>https://mp.weixin.qq.com/s/k9juW0c9bm1GAsyE9Zvm_A</link><description></description><content:encoded><![CDATA[一文盘点侵袭性 B 细胞淋巴瘤免疫治疗药物]]></content:encoded><pubDate>Thu, 22 Apr 2021 11:31:44 +0800</pubDate></item><item><title>速递丨膀胱癌新型ADC药物Padcev获FDA优先审查！</title><link>https://mp.weixin.qq.com/s/J7Dky_N1KoF6tJjagkXDwQ</link><description></description><content:encoded><![CDATA[速递丨膀胱癌新型ADC药物Padcev获FDA优先审查！]]></content:encoded><pubDate>Thu, 22 Apr 2021 11:31:44 +0800</pubDate></item><item><title>临床试验丨 结直肠癌（三）</title><link>https://mp.weixin.qq.com/s/ufN1zZ5cPPdxmFpRSe-0yw</link><description></description><content:encoded><![CDATA[临床试验丨 结直肠癌（三）]]></content:encoded><pubDate>Wed, 21 Apr 2021 14:16:03 +0800</pubDate></item><item><title>可能比想象的还要难！治疗EGFR T790M突变非小细胞肺癌的最新研究解读</title><link>https://mp.weixin.qq.com/s/R_4J7wtIx1SWnIcl5Rm5gQ</link><description></description><content:encoded><![CDATA[可能比想象的还要难！治疗EGFR T790M突变非小细胞肺癌的最新研究解读]]></content:encoded><pubDate>Tue, 20 Apr 2021 11:20:39 +0800</pubDate></item><item><title>速递丨首个STING激动剂获批临床，拟开展治疗晚期实体瘤临床研究！</title><link>https://mp.weixin.qq.com/s/UaoCkjH_pxRYGxrQMV5cbg</link><description></description><content:encoded><![CDATA[速递丨首个STING激动剂获批临床，拟开展治疗晚期实体瘤临床研究！]]></content:encoded><pubDate>Tue, 20 Apr 2021 11:20:39 +0800</pubDate></item><item><title>一文盘点原发性肝癌分层筛查与监测要点</title><link>https://mp.weixin.qq.com/s/DdRcjm-I-9Sv_XewavrS5Q</link><description></description><content:encoded><![CDATA[一文盘点原发性肝癌分层筛查与监测要点]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:00:58 +0800</pubDate></item><item><title>速递丨君实PD-1尿路上皮癌适应症正式获批；发现结直肠癌治疗新靶标</title><link>https://mp.weixin.qq.com/s/t7QNTbXi2hINFGiT-L30mg</link><description></description><content:encoded><![CDATA[速递丨君实PD-1尿路上皮癌适应症正式获批；发现结直肠癌治疗新靶标]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:00:58 +0800</pubDate></item></channel></rss>